These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8724787)

  • 1. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
    Eckert S; Eyer P; Worek F
    Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New data on the pharmacokinetics of aminostigmine].
    Prozorovskiĭ VB; Chepur SV; Vorob'ev-Desiatovskiĭ NV; Panov PB
    Eksp Klin Farmakol; 1998; 61(5):46-9. PubMed ID: 9854634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
    Prozorovskiĭ VB; Sazonova AV
    Eksp Klin Farmakol; 1995; 58(5):57-61. PubMed ID: 8704593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the decarbamylation process of cholinesterase during assay of enzyme activity.
    Rotenberg M; Almog S
    Clin Chim Acta; 1995 Sep; 240(2):107-16. PubMed ID: 8548921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bizerine: new anticholinesterase drug with selective gastrointestinal action].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Shchemeleva NI
    Eksp Klin Farmakol; 2010 Aug; 73(8):14-6. PubMed ID: 20919551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
    Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histamine blockers increase efficacy of specific antidote prophylaxis of intoxication by cholinesterase inhibitors in mice].
    Prozorovskiĭ VB; Skopichev VG; Ditiateva ZhA; Sazonova AV
    Eksp Klin Farmakol; 2000; 63(4):64-7. PubMed ID: 11022312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
    Prozorovskiĭ VB; Iudkina NI
    Anesteziol Reanimatol; 1991; (1):25-6. PubMed ID: 1862957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Eckert S; Eyer P; Herkert N; Bumm R; Weber G; Thiermann H; Worek F
    Biochem Pharmacol; 2008 Feb; 75(3):698-703. PubMed ID: 17977518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F; Thiermann H; Szinicz L
    Arch Toxicol; 2004 Apr; 78(4):212-7. PubMed ID: 14647978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods.
    Eckert S; Eyer P; Melzer M; Thiermann H; Worek F
    Biochem Pharmacol; 2008 Apr; 75(7):1561-6. PubMed ID: 18281016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cholinesterase activity: understanding and interpretation.
    Jokanović M; Maksimović M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):11-6. PubMed ID: 9156559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of reactivation techniques for carbamate-inhibited brain and plasma cholinesterases in birds and mammals.
    Hunt KA; Hooper MJ
    Anal Biochem; 1993 Aug; 212(2):335-43. PubMed ID: 8214574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
    Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
    Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Musilova L; Kuca K; Jung YS; Jun D
    Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.